(IN BRIEF) CVC Strategic Opportunities II has successfully exited its investment in Genetic S.p.A., a pharmaceutical CDMO specializing in Respiratory, Ophthalmic, and Oncology therapeutic products. The exit sees NB Renaissance and NB Aurora joining the Pavese family as shareholders. Under … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Italy, Luxembourg, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged CVC Strategic Opportunities II, exit, FRM Tax, Genetic S.p.A., international expansion, investment, NB Aurora, NB Renaissance, oncology, Ophthalmic, partnership, Pavese family, PedersoliGattai, pharmaceutical CDMO, pharmaceutical industry, Product Development, PwC, respiratory, Rocco Pavese, Rothschild & Co., strategic growth
(PRESS RELEASE) STOCKHOLM, 20-Dec-2022 — /EuropaWire/ — EQT, a purpose-driven global investment organization, has announced that its BPEA V Fund will divest Bushu Pharmaceuticals, a leading CMO in Japan that produces high-quality pharmaceutical and medical devices, by selling it to … Read the full press release
Posted in Business, Investment, Management, News, Pharma & Biotech, Sweden
Tagged BPEA EQT, BPEA V Fund, Bushu Pharmaceuticals, CDMO, EQT, Japan, JP Morgan, Kawagoe, KKR, medical devices, Pharmaceutical, pharmaceutical CDMO, Sanwa Kagaku Kenkyusho, Tadao Takano, Tadashi Maruoka, Tetsuichi Okada, Tetsuya Morikawa, Wes Wheeler
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?